Legal status by country
Is Neurotensin legal?
Written by Aaron CuhaReviewed Sep 2026
How Neurotensin is classified in the United States, United Kingdom, Australia and Canada, side by side. Each country has its own page with a direct answer, the regulator's approval status and what the classification means in practice.
All four countries, side by side
| Attribute | United States · FDA | United Kingdom · MHRA | Australia · TGA | Canada · Health Canada |
|---|---|---|---|---|
| Status | Not approved | Not approved | Not approved | Not approved |
| Classification | Not a medicine; endogenous signalling molecule | Not a medicine; endogenous signalling molecule | Not a medicine; endogenous signalling molecule | Not a medicine; endogenous signalling molecule |
| Note | A peptide the body produces, not a product. No approved drug acts as a neurotensin receptor agonist. The only clinically tested molecule at this receptor located in this pass is the NTSR1 antagonist SR48692, which was studied in ovarian cancer, not pain. | Not a medicinal product. No licensed agonist at this receptor. | Not a therapeutic good. No registered agonist at this receptor. | Not a drug product. No authorised agonist at this receptor. |
US FDA status: Neurotensin is an endogenous peptide and is not a medicine. No neurotensin product or neurotensin receptor agonist is approved in any jurisdiction, and no interventional trial of either for pain is registered.. Reviewed Sep 2026.
Related compounds
General information current as of Sep 2026, not legal advice. Classifications change; confirm with the regulator or a lawyer for a specific situation. Educational use only. This database summarizes published research. It is not medical advice and contains no dosing protocols or recommendations for personal use. The Longevity Archive has no vendor relationships.